Net profit of Rossari Biotech rose 4.39% to Rs 36.88 crore in the quarter ended September 2025 as against Rs 35.33 crore during the previous quarter ended September 2024. Sales rose 17.61% to Rs 586.11 crore in the quarter ended September 2025 as against Rs 498.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales586.11498.35 18 OPM %12.2713.23 - PBDT67.9163.27 7 PBT49.6748.11 3 NP36.8835.33 4 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 15 October 2025.Powered by Capital Market - Live News

Net profit of Rossari Biotech declined 3.72% to Rs 33.60 crore in the quarter ended June 2025 as against Rs 34.90 crore during the previous quarter ended June 2024. Sales rose 11.04% to Rs 543.72 crore in the quarter ended June 2025 as against Rs 489.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales543.72489.65 11 OPM %12.4813.25 - PBDT63.8562.36 2 PBT46.1046.99 -2 NP33.6034.90 -4 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 July 2025.Powered by Capital Market - Live News

Rossari Biotech announced that the 16th Annual General Meeting(AGM) of the company will be held on 30 June 2025.Powered by Capital Market - Live News